Cancer Counseling Hotline(+60) 7 232 3406
(+60) 19 778 9333
|Vietnam||Tiếng Việt English|
Dr Richard Quek from Parkway Cancer Centre and Dr Leon Foo from Island Orthopaedic Consultants talk about how this tumour is discovered and treated.
Dr Quek: Sarcomas are cancers that develop from the mesenchymal layer, the layer which goes on to form connective tissue, fat cells, muscles, blood vessels and bones. Sarcomas may thus arise from various parts of the body, including skin, connective tissue, bones, blood vessels and even deep organs.
Dr Foo: Sarcomas and cancers are both malignant tumours. Their difference is in the cell of origin. Cancers arise from epidermal and endodermal tissue, while sarcomas arise from mesodermal tissue, such as bone, cartilage, muscle, nerves, blood vessels and fat.
Dr Quek: There are more than 70 different subtypes, broadly divided into bone and soft tissue tumours. Bone sarcomas originate primarily from the bones; the most common forms are osteosarcoma (bone), chondrosarcoma (cartilage) and chordoma (notochord). Soft tissue sarcoma is a complex group of sarcomas, with more than 50 distinct subtypes.
Dr Quek: Soft tissue sarcoma is not common: It is seen in five out of 100,000 persons, though it affects younger people disproportionately. Gastrointestinal stromal tumour (GIST), distinct from soft tissue sarcoma, develops from the gastrointestinal tract and is one of the most common forms of sarcomas. It is seen in two out of 100,000 persons.
Dr Foo: Sarcomas account for about one per cent of malignant tumours. While they are less common, however, many of them affect children and young adults, making them socially and economically significant diseases.
Dr Foo: The most common presentation is a lump, often painless. This lump may be hard or soft, large or small, growing fast or slowly. Patients may also have a myriad of generic/non-specific symptoms such as pain, numbness/altered sensation, abdominal distension, difficulty in swallowing and shortness of breath.
Dr Quek: Soft tissue sarcomas typically appear as a mass and may grow to be as large as 20cm or more. Depending on where it is located, it may cause different symptoms, such as a cough (if it is in the chest), limb or abdominal swelling. There may or may not be pain associated with the tumour masses. For bone sarcomas, symptoms include bone pain, bone swelling, and fractures after minimal trauma.
Dr Foo: Very rarely. The vast majority of sarcomas are due to genetic aberrations, such as spontaneous mutations and genetic re-arrangements. Some patients may, however, be predisposed such as patients with certain rare, inherited/familial syndromes like neurofibromatosis, retinoblastoma, Gardner’s syndrome and Li-Fraumeni syndrome.
Dr Foo: The gold standard is a tissue biopsy to give a proper histological diagnosis.
Dr Foo: The treatment of both bone and soft tissue sarcomas has evolved considerably in the past two to three decades. We are starting to understand sarcomas better and now know that certain histological subtypes respond better to specific modalities of treatment. For example, some sarcomas such as Ewing’s sarcoma are very chemo-sensitive, while other sarcomas such as chondrosarcoma are best treated with surgery alone. The focus now is on targeted therapy, aiming for greater clinical efficacy and less treatment side effects.
Dr Quek: Soft tissue sarcoma is best treated with a combination of surgery, radiation and/or chemotherapy, while osteosarcoma is usually treated with chemotherapy followed by surgery. Wherever possible, we avoid amputation. In osteosarcoma, the use of chemotherapy is crucial and has been shown to triple the survival rates, from 20 per cent with surgery alone to 70 per cent with surgery and chemotherapy.
Dr Quek: The prognosis for those with soft tissue sarcoma is promising and improving, with a good chance of cure or remission following treatment. In selected patients with advanced soft tissue sarcoma which has spread, long-term remission can still be achieved with aggressive multi-modality treatment. In bone sarcomas such as osteosarcoma, with surgery and chemotherapy, cure rates of 70 per cent are achieved in patients with localised disease.
While in gastrointestinal stromal tumours (GIST), treatment paradigm has been completely revolutionised with the discovery of effective targeted therapies. Imatinib, an oral drug which blocks the mutation driving GIST, has been shown to shrink tumours in more than two-thirds of GIST patients, raising the median survival rate to more than five years, even in patients with Stage 4 disease.
And in Ewing’s sarcoma (EWS), survival rates are also high – the long-term survival rate in patients with localised EWS is 75 per cent and even in patients with advanced metastatic disease, long-term remission rates of more than 25 per cent are achieved.
Dr Foo: No, not all patients require surgery for sarcoma. Those with advanced sarcomas are sometimes offered chemotherapy or palliative care, as the sarcomas may involve too many major structures to be safely removed. Having said this, most sarcomas do usually require surgery to remove the “motherload” of malignant tumour tissue.
Dr Foo: No, not all sarcomas need radiation or chemotherapy after surgery. A lot depends on the exact histological diagnosis, as well as the resected sarcoma specimen’s surgical margins. If the surgical margins are wide, then the risk of local sarcoma recurrence is considerably reduced. Thus additional radiation to the surgical site may not be needed. Similarly chemotherapy may not be needed in most sarcomas following surgery except in cases of osteosarcoma, Ewing’s sarcoma, rhabdomyosarcoma and selected high-risk GIST cases where chemotherapy following surgery confers significant survival benefits.
While less common than other cancers, sarcomas are generally aggressive.
Sarcomas are a complex disease with more than 70 subtypes, broadly divided into bone and soft tissue tumours. More specifically, there are four main groups: Soft tissue sarcoma, Bone sarcomas, Gastrointestinal stromal tumour, and Ewing’s sarcoma and Rhabdomyosarcoma.
Such cancers develop from the mesenchymal layer of our body. They may arise from various parts of the body including skin, connective tissues, bones, blood vessels and even deep organs.
Written by Kok Bee Eng
|POSTED IN||Cancer Treatments|
|TAGS||cancer diagnosis , primary bone cancer , sarcoma , tumours|
|READ MORE ABOUT||Sarcoma|